跳至主要内容
临床试验/NCT01739907
NCT01739907已完成不适用

Iron-fortified Flavoured Skimmed Milk With or Without Vitamin D in Iron Deficient Women

National Research Council, Spain0 个研究点目标入组 109 人开始时间: 2012年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
109
主要终点
Ferritin changes over 16 weeks

研究概览

简要总结

Iron deficiency and vitamin D deficiencies are common in menstruating women. The present assay studied the influence of the consumption of a flavoured skimmed milk with iron (iron pyrophosphate) or with iron and vitamin D3 in iron deficient women on:

  • Iron metabolism
  • Biomarkers of bone remodelling
  • Cardiovascular risk indexes

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 35 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Non-smoker or smokers of ≤ 3 cigarettes/day
  • Non-pregnant
  • non-breast-feeding
  • Serum ferritin <30ng/mL
  • Haemoglobin ≥11g/dL

排除标准

  • Amenorrhea
  • Menopause
  • Any known health problems likely to influence iron status including iron-metabolism-related diseases (iron deficiency anaemia, thalassaemia, haemochromatosis)
  • Chronic gastric diseases (inflammatory bowel disease, Crohn disease, gastric ulcers, celiac disease, hemorrhagic diseases)
  • Renal disease or allergy to some of the components of the assay diary product.
  • Blood donors
  • Have regularly consumed iron or ascorbic acid supplements within the four months prior to participating in the intervention.

结局指标

主要结局

Ferritin changes over 16 weeks

时间窗: 16 weeks (Measures at 0, 4, 8, 12 and 16 weeks)

次要结局

  • Haemoglobin changes over 16 weeks(16 weeks (Measures at 0, 4, 8, 12 and 16 weeks))
  • Total erythrocytes changes over 16 weeks(16 weeks (Measures at 0, 4, 8, 12 and 16 weeks))
  • Haematocrit changes over 16 weeks(16 weeks (Measures at 0, 4, 8, 12 and 16 weeks))
  • Mean corpuscular volume changes over 16 weeks(16 weeks (Measures at 0, 4, 8, 12 and 16 weeks))
  • Red blood cell distribution width changes over 16 weeks(16 weeks (Measures at 0, 4, 8, 12 and 16 weeks))
  • Serum iron changes over 16 weeks(16 weeks (Measures at 0, 4, 8, 12 and 16 weeks))
  • Serum transferrin changes over 16 weeks(16 weeks (Measures at 0, 4, 8, 12 and 16 weeks))
  • Transferrin saturation changes over 16 weeks(16 weeks (Measures at 0, 4, 8, 12 and 16 weeks))
  • Soluble transferrin receptor changes over 16 weeks(16 weeks (Measures at 0, 8, and 16 weeks))
  • 25-hydroxyvitamin D changes over 16 weeks(16 weeks (Measures at 0, 8, and 16 weeks))
  • Procollagen type 1 N-terminal propeptide (P1NP) changes over 16 weeks(16 weeks (measures at 0, 8 and 16 weeks))
  • Cross-linked N-telopeptides of type I collagen (NTX) changes over 16 weeks(16 weeks (measures at 0, 8 and 16 weeks)
  • Parathormone (PTH) changes over 16 weeks(16 weeks (measures at 0, 8 and 16 weeks)
  • Total cholesterol changes over 16 weeks(16 weeks (Measures at 0, 8 and 16 weeks)
  • LDL-cholesterol changes over 16 weeks(16 weeks (Measures at 0, 8 and 16 weeks))
  • HDL-cholesterol changes over 16 weeks(16 weeks (Measures at 0, 8 and 16 weeks))
  • Triglycerides changes over 16 weeks(16 weeks (Measures at 0, 8 and 16 weeks))
  • Systolic blood pressure changes over 16 weeks(16 weeks (Measures at 0, 8 and 16 weeks))
  • Diastolic blood pressure changes over 16 weeks(16 weeks (Measures at 0, 8 and 16 weeks))
  • glucose changes over 16 weeks(16 weeks (Measures at 0, 8 and 16 weeks))

研究者

发起方
National Research Council, Spain
申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

M Pilar Vaquero

Scientific researcher

National Research Council, Spain

相似试验